Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as
Case Western Reserve´s new vice president for research, effective this month.
Rivera, the university´s associate vice president for research since January 2011,
emerged as the top choice after an extensive process involving campuswide nominations
of internal university candidates. Since coming to CWRU, Rivera has distinguished herself
through a commitment to collaboration and a focus on systems and processes.
Read more about her.
Click here to view previous editions of Research Matters and Research News and Updates.
December 9, 2014
National Institutes of Health (NIH)
The National Institutes of Health, Department of Health and Human Services has announced the following new funding opportunity:
The CTSC Annual Pilot Program is for researchers to conduct innovative translational research projects focused on the invention, preclinical development and/or first in man studies of novel therapeutic agents, biomedical devices, and diagnostics designed to address unmet clinical needs. Funding is intended to facilitate development of enabling technologies; new therapeutic, diagnostic or outcomes assessment approaches and/or device; novel cross-disciplinary collaborative programs; and promote research in the community.
Research which may create intellectual property is encouraged. If funding would enhance an existing non-federally funded project or enable a proposal to a federal agency for use of CTSC and CCTRP resources, the application would be considered. This pilot has few restrictions and allows for the hiring of personnel. Researchers new to clinical research, clinical research scholars, or experienced researchers who are moving into a new area of research are strongly encouraged to apply.
Available Funds: Up to $50,000 per project for up to one year of support.
Deadline for Letter of Intent: January 15, 2015.
For questions contact:
CTSC Pilot Program Office:
The Wellcome Trust is a UK-based organization that funds research to improve human and animal health. The Wellcome Trust supports research conducted outside the UK where research develops international partnerships, or focuses on biomedical or clinical medicine in developing countries.
The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.
The prize is administered by the National Multiple Sclerosis Society. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research
New Facilities and Administrative (F&A) Rate for Use in Proposals
Negotiations with the Department of Health and Human Services (DHHS) regarding the University’s F&A rates have concluded. DHHS has approved a (3) three year F&A rate of 58.5% for CWRU, which is a 1.5 percentage point change from our previous rate of 57%. This rate will be effective through June 2016.
The new F&A rate should be used when preparing proposal budgets for awards with an anticipated start date of July 1, 2013 or after.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be